Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Labcorp Holdings Inc's Business Segments
Labcorp Holdings Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q1 FY2026
Reportable Segments
2
Largest Segment
Diagnostics
Total Revenue
$ 3,538
Regions Reported
-
Revenue Share by Reportable Segment - Q1 FY2026
- Diagnostics78.1%
- Biopharma Laboratory Services22.1%
Revenue by Reportable Segment - Q1 FY2026
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Diagnostics | $ 2,762 | 78.1% |
| Biopharma Laboratory Services | $ 781 | 22.1% |
Description of Labcorp Holdings Inc
Laboratory Corporation of America Holdings, commonly known as Labcorp, is a leading independent clinical laboratory company in the United States, headquartered in Burlington, North Carolina. The company operates a comprehensive national network of laboratories and offers an extensive portfolio of over 4,400 clinical laboratory tests. These tests play a crucial role in patient diagnosis, routine testing, and the ongoing monitoring and treatment of various diseases.
Labcorp is known for its broad range of testing services, including routine laboratory tests, specialized assays, and niche testing capabilities tailored to specific client needs. Notable areas of expertise include oncology testing, HIV genotyping and phenotyping, diagnostic genetics, and support for clinical research trials.
In recent years, Labcorp has significantly bolstered its capabilities and service offerings through strategic acquisitions, including Dynacare Inc. and DIANON Systems, Inc. These expansions enhance Labcorp’s ability to provide specialized testing and broaden its reach within the healthcare sector.
Overall, Labcorp stands out in the laboratory services industry due to its commitment to innovation, quality, and comprehensive testing solutions that support healthcare providers and patients alike.
Labcorp is known for its broad range of testing services, including routine laboratory tests, specialized assays, and niche testing capabilities tailored to specific client needs. Notable areas of expertise include oncology testing, HIV genotyping and phenotyping, diagnostic genetics, and support for clinical research trials.
In recent years, Labcorp has significantly bolstered its capabilities and service offerings through strategic acquisitions, including Dynacare Inc. and DIANON Systems, Inc. These expansions enhance Labcorp’s ability to provide specialized testing and broaden its reach within the healthcare sector.
Overall, Labcorp stands out in the laboratory services industry due to its commitment to innovation, quality, and comprehensive testing solutions that support healthcare providers and patients alike.
Labcorp Holdings Inc. is a major global player in the life sciences sector, predominantly recognized for its comprehensive medical laboratory services, diagnostic testing, and drug development offerings. The companys operations are primarily encapsulated within one principal segment, Labcorp Diagnostics, which delivers a broad spectrum of critical healthcare services catering to healthcare providers, pharmaceutical firms, and research organizations.
1. Labcorp Diagnostics
The Labcorp Diagnostics segment is the cornerstone of the company’s operations. It emphasizes high-quality laboratory services and diagnostic testing services across various medical disciplines. The offerings in this segment can be categorized into the following key areas:
a. Clinical Laboratory Services
Labcorp’s clinical laboratory services are extensive, supporting healthcare professionals in the diagnosis, monitoring, and management of various medical conditions. The services can be further broken down into:
- Routine Testing: This includes general laboratory tests, such as blood tests, urinalysis, and other common diagnostic procedures that are essential in routine medical examinations.
- Specialty Testing: Labcorp offers advanced diagnostic tests spanning diverse medical fields such as endocrinology, toxicology, cardiology, and infectious diseases, catering to more complex patient needs.
- Genetic Testing: A comprehensive suite of genetic testing services is available, including:
- Carrier Screening for inherited genetic conditions.
- Hereditary Cancer Testing to assess risks for certain types of cancers.
- Pharmacogenomics to predict how patients will respond to medications based on their genetic makeup.
- Prenatal Testing to evaluate the health of the fetus during pregnancy.
- Pathology Services: Labcorp provides a wide range of pathology services, which include:
- Anatomic Pathology: Involves the examination of tissues and cells to diagnose diseases.
- Histology and Cytology: Specialized tests focusing on microscopic examination of tissues and cellular material.
- Molecular Pathology: Advanced techniques to analyze genetic material for diagnostics.
b. Point-of-Care Testing
Labcorp extends its services to include point-of-care testing solutions, creating convenience for healthcare providers and patients. These offerings consist of:
- Rapid Diagnostic Tests: These tests, which can be conducted quickly, include diagnostics for conditions such as COVID-19, influenza, strep throat, and pregnancy.
- Home Health Testing: This service allows patients to conveniently collect samples at home for various tests, improving access to healthcare.
c. Patient Services
Enhancing the patient experience is a priority for Labcorp, which provides a variety of patient services, including:
- Lab Locations: A vast network of patient service centers is available for individuals to access convenient testing options.
- Mobile Health Solutions: Offerings for at-home sample collection cater to patients who may have difficulty visiting traditional lab settings.
Drug Development Services
Complementing its diagnostics portfolio, Labcorp plays a significant role in drug development through its Labcorp Drug Development segment. This branch is integral for pharmaceutical and biotechnology companies involved in the journey to develop new drugs. Key offerings include:
a. Preclinical and Clinical Development
Labcorp provides a wide array of services throughout the drug development lifecycle:
- Preclinical Services: This consists of both in vitro (test tube experiments) and in vivo (animal studies) assessments to gauge the safety and efficacy of new compounds.
- Clinical Trials: The company manages clinical trials at all phases (Phase I to IV), offering extensive support that includes study design, patient recruitment, monitoring, and data analysis.
b. Central Laboratory Services
Labcorp maintains central laboratories that provide laboratory testing specifically for clinical trials, including:
- Sample Management: This encompasses logistics, processing, and tracking of samples obtained from trial sites.
- Data Management: Leveraging advanced data analytics to ensure precise reporting and compliance with regulatory standards.
c. Regulatory and Consultation Services
Navigating the complex regulatory landscape of drug development can be challenging, and Labcorp offers valuable consultation and advisory services:
- Regulatory Affairs: Providing guidance on submissions and interactions with regulatory agencies, including the FDA.
- Scientific & Statistical Services: Delivering expertise in biostatistics, data management, and clinical analytics to support drug development projects.
Specialized Areas
Labcorp emphasizes specialized testing to augment its service offerings, notably in:
a. Women’s Health
A focused suite of testing services designed for womens health issues, including reproductive health and prenatal testing options.
b. Oncology
Targeted testing services tailored for cancer diagnostics and monitoring. This includes innovative techniques such as liquid biopsies and tumor profiling to inform treatment decisions.
c. Infectious Disease
Comprehensive testing services for a wide array of infectious diseases are provided, including HIV, hepatitis, and a range of emerging pathogens, which are vital in surveillance and management of public health.
Innovation and Technology
Labcorp is committed to integrating innovative technology within its operations to enhance service delivery:
- Digital Solutions: Platforms that promote patient engagement, facilitate telemedicine consultations, and streamline electronic test ordering.
- Laboratory Automation: Employing automated systems to improve testing efficiency, accuracy, and throughput in laboratory operations.
Conclusion
Labcorp Holdings Inc. represents a leader in laboratory diagnostics and drug development services, with a rich and diverse array of testing capabilities. Through its unwavering commitment to high-quality diagnostics, patient service innovation, and an array of specialized offerings, Labcorp plays a critical role in driving healthcare advancements and supporting the pharmaceutical industry in drug development endeavors. This broad and integrated approach illustrates Labcorps mission to enhance health outcomes and improve lives on a global scale.
1. Labcorp Diagnostics
The Labcorp Diagnostics segment is the cornerstone of the company’s operations. It emphasizes high-quality laboratory services and diagnostic testing services across various medical disciplines. The offerings in this segment can be categorized into the following key areas:
a. Clinical Laboratory Services
Labcorp’s clinical laboratory services are extensive, supporting healthcare professionals in the diagnosis, monitoring, and management of various medical conditions. The services can be further broken down into:
- Routine Testing: This includes general laboratory tests, such as blood tests, urinalysis, and other common diagnostic procedures that are essential in routine medical examinations.
- Specialty Testing: Labcorp offers advanced diagnostic tests spanning diverse medical fields such as endocrinology, toxicology, cardiology, and infectious diseases, catering to more complex patient needs.
- Genetic Testing: A comprehensive suite of genetic testing services is available, including:
- Carrier Screening for inherited genetic conditions.
- Hereditary Cancer Testing to assess risks for certain types of cancers.
- Pharmacogenomics to predict how patients will respond to medications based on their genetic makeup.
- Prenatal Testing to evaluate the health of the fetus during pregnancy.
- Pathology Services: Labcorp provides a wide range of pathology services, which include:
- Anatomic Pathology: Involves the examination of tissues and cells to diagnose diseases.
- Histology and Cytology: Specialized tests focusing on microscopic examination of tissues and cellular material.
- Molecular Pathology: Advanced techniques to analyze genetic material for diagnostics.
b. Point-of-Care Testing
Labcorp extends its services to include point-of-care testing solutions, creating convenience for healthcare providers and patients. These offerings consist of:
- Rapid Diagnostic Tests: These tests, which can be conducted quickly, include diagnostics for conditions such as COVID-19, influenza, strep throat, and pregnancy.
- Home Health Testing: This service allows patients to conveniently collect samples at home for various tests, improving access to healthcare.
c. Patient Services
Enhancing the patient experience is a priority for Labcorp, which provides a variety of patient services, including:
- Lab Locations: A vast network of patient service centers is available for individuals to access convenient testing options.
- Mobile Health Solutions: Offerings for at-home sample collection cater to patients who may have difficulty visiting traditional lab settings.
Drug Development Services
Complementing its diagnostics portfolio, Labcorp plays a significant role in drug development through its Labcorp Drug Development segment. This branch is integral for pharmaceutical and biotechnology companies involved in the journey to develop new drugs. Key offerings include:
a. Preclinical and Clinical Development
Labcorp provides a wide array of services throughout the drug development lifecycle:
- Preclinical Services: This consists of both in vitro (test tube experiments) and in vivo (animal studies) assessments to gauge the safety and efficacy of new compounds.
- Clinical Trials: The company manages clinical trials at all phases (Phase I to IV), offering extensive support that includes study design, patient recruitment, monitoring, and data analysis.
b. Central Laboratory Services
Labcorp maintains central laboratories that provide laboratory testing specifically for clinical trials, including:
- Sample Management: This encompasses logistics, processing, and tracking of samples obtained from trial sites.
- Data Management: Leveraging advanced data analytics to ensure precise reporting and compliance with regulatory standards.
c. Regulatory and Consultation Services
Navigating the complex regulatory landscape of drug development can be challenging, and Labcorp offers valuable consultation and advisory services:
- Regulatory Affairs: Providing guidance on submissions and interactions with regulatory agencies, including the FDA.
- Scientific & Statistical Services: Delivering expertise in biostatistics, data management, and clinical analytics to support drug development projects.
Specialized Areas
Labcorp emphasizes specialized testing to augment its service offerings, notably in:
a. Women’s Health
A focused suite of testing services designed for womens health issues, including reproductive health and prenatal testing options.
b. Oncology
Targeted testing services tailored for cancer diagnostics and monitoring. This includes innovative techniques such as liquid biopsies and tumor profiling to inform treatment decisions.
c. Infectious Disease
Comprehensive testing services for a wide array of infectious diseases are provided, including HIV, hepatitis, and a range of emerging pathogens, which are vital in surveillance and management of public health.
Innovation and Technology
Labcorp is committed to integrating innovative technology within its operations to enhance service delivery:
- Digital Solutions: Platforms that promote patient engagement, facilitate telemedicine consultations, and streamline electronic test ordering.
- Laboratory Automation: Employing automated systems to improve testing efficiency, accuracy, and throughput in laboratory operations.
Conclusion
Labcorp Holdings Inc. represents a leader in laboratory diagnostics and drug development services, with a rich and diverse array of testing capabilities. Through its unwavering commitment to high-quality diagnostics, patient service innovation, and an array of specialized offerings, Labcorp plays a critical role in driving healthcare advancements and supporting the pharmaceutical industry in drug development endeavors. This broad and integrated approach illustrates Labcorps mission to enhance health outcomes and improve lives on a global scale.